Post a Free Blog

Submit A Press Release

Thursday, March 28, 2024
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Truck Series (TRUCK)
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
-- Advertisement --spot_img
HomeBusinessModerna announces single dose COVID, and Flu vaccine shot, vaccines for children,...

Moderna announces single dose COVID, and Flu vaccine shot, vaccines for children, shares rise

 

On Thursday, Moderna announced that it is developing a vaccine booster with double benefits. It would work against both COVID and the seasonal flu. Moderna shares rose by over 5 percent after the announcement. Moderna also announced that it was developing vaccines for children.

 

In a statement on research and development day 2021 the company said that it is developing a combined vaccine called mRNA-1073 that encodes for both the spike protein in SARS Cov2 or COVID as well as HA glycoproteins in flu.

 

On Thursday, CEO Stephane Bancel said that they were announcing their first step in their novel respiratory program which would combine a booster against COVID-19 and a booster against flu in a single dose.

 

He also said that they were progressing in enrolling patients in their rare diseases program. They also had enrollment in their personalized cancer vaccine trial. He also said that Moderna believed that it was the beginning of a new age of “information-based medicines.”

 

The two-dose based Moderna vaccine had received emergency approval authorization by the FDA in December 2020 and the Centers for Disease Control and Prevention (CDC) said that Americans have received over 147 million shots of the Moderna vaccine.

 

Moderna also announced that it was developing a pediatric vaccine. The vaccine for children is called mRNA1365. It will combine vaccines for respiratory syncytial virus (RSV), cases of which have been seen seasonally earlier than normal this year and human metapneumovirus.

 

The company also said that the European Union and other jurisdictions have given it authorization for using its COVID-19 vaccine for children   ages 12 and above. On August 25, it completed the process for a biologics license application for its vaccine in the nation.

 

The company also said that it had 37 programs that were in development across 34 development candidates which included 22 ongoing clinical studies. Its cash position, end August was approximately $15 billion.

Subscribe to get Latest News Updates

Latest News Articles

You may like more
more

Google code on Pinterest app suggests potential test of ad units, CWEB analysts say

Google and Pinterest might be testing a new partnership....

DraftKings Falls, NCAA Wants to Ban College Prop Bets. CWEB analysts issue Hold Rating on the stock.

Shares of DraftKings Inc.(DKNG) experienced a significant decline on...

Chick-Fil-A backtracks on NAE pledge, to use some antibiotics in chicken

Chick-Fil-A backtracked on its No Antibiotics Ever (NAE) policy...

Bloom Energy’s Price Target Cut at Susquehanna

Susquehanna analysts adjusted their price target for Bloom Energy...